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Introduction 
Withdrawal symptoms occur in substance-dependent 
people when the drug or its equivalent is not available 
for use. These symptoms include anxiety, restlessness, 
insomnia, nausea and vomiting, diarrhea, muscle 
cramp (leg and abdominal muscle), sweating, rhinorrea 
or epiphora, involuntary muscle contraction or muscle 
twitching, and sometimes convulsion. If dependence is 
severe, the withdrawal symptoms last for 6-10 days. 
The severity of symptoms depends on the degree of 
dependence. Psychological dependence is the desire for 
drug use and the psychological symptoms of with-
drawal takes much more time than physical depen-
dence (Ferriola et al., 1989).  
The chemical compounds in some plants affect drug 
withdrawal through different cerebral systems, such as 
gabaergic and dopaminergic systems, and therefore 
cause sedation and relief in substance-dependent 
people. 
Seed oil, leaves, flowers and flowering shoots of Borago 
officinalis are used in traditional medicine. The com-
pounds of B. officinalis seed oil include β-caryophyllene,
p-simen-8-L, monoterpenes, sesquiterpenes, gamma-
linoleic acid, linoleic acid and alpha-linoleic acid. The
main compounds identified in B. officinalis leaves
include phenolic acids, flavonoids and organic acids
(Asadi Samani et al., 2014).
Hydroalcoholic extract of B. officinalis flower is able to 
relieve the severe and acute pain (Shahraki et al., 2015).
B. officinalis is rich in unsaturated fatty acids, especially
linoleic acid. The use of B. officinalis causes neurons'
membrane to repair more rapidly and hence the process
of receiving and transmitting neural messages is
improved. Clinical studies have indicated that the use
of B. officinalis seed oil reduces cerebral arteriosclerosis
by up to 30%. In addition, this oil contributes to
improving memory and reducing affective arousal
(Pieszak et al., 2012).
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Abstract
The aim of the present study was to investigate the effect of hydroalcoholic 
extract of Borago officinalis on morphine withdrawal syndrome in mice. 
Morphine-dependent group received morphine for nine days and then 
received naloxone via intraperitoneal injection.  Control group received saline 
for nine days. Post-treated group received B. officinalis extract intraperito-
neally (100 mg/kg) on the day 10 before naloxone injection. Co-treated group 
received B. officinalis extract intraperitoneally (100 mg/kg) and morphine for 
nine days and then received naloxone. Extract-treated group received extract 
for nine days and then received naloxone. Naloxone injection significantly 
increased the frequency of jumping, blinking, ptosis, defecation, paw tremb-
ling, and two-legged standing in comparison to the control group. Co-
treatment and post-treatment with B. officinalis extract significantly decreased 
the withdrawal symptoms. In conclusion, hydroalcoholic extract of B. 
officinalis significantly attenuated the symptoms of morphine withdrawal 
syndrome.  
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Materials and Methods 
Extracting
B. officinalis flowers were provided from the reliable
groceries of Shahrekord. After the flowers were
identified and ground, they were mixed with alcohol
70%. The solution was kept at room temperature for
one week. Then, the extract filtered and the filtered
solution was left at 37°C temperature for evaporation of
alcohol and water in it (Ghahremanitamadon et al.,
2014).
Determining phenolic compounds
Briefly, 0.5 mL Folin-Ciocalteu reagent was introduced 
into 0.1 mL of the diluted extract (0.01 g/10 mL 
methanol at 60°C temperature). After 3-4 min, 0.4 mL 
sodium carbonate 7.5% was added to the solution. After 
30 min incubation at room temperature, the absorbance 
of the samples was read against distilled water used as 
blank. During the experiment, different dilutions of 
gallic acid were prepared and standard curve was 
derived. The samples' absorbance was compared with 
the standard curve and the extract's total phenol was 
calculated and expressed in mg/g dried extract (Rabiei 
et al., 2014). 
Determining flavonolid compounds
Briefly, 0.5 mL of the extract solution (0.01 g/10 mL 
methanol at 60°C temperature) was dissolved with 0.5 
mL aluminum chloride 2%. Then, 3 mL potassium 
acetate was introduced into the solution. After 40 min, 
the absorbance of samples was read against distilled 
water at 440 nm wavelength. During the experiment, 
different dilutions at routine concentrations were 
prepared and tested according to the above method and 
the standard curve was derived. The samples' 
absorbance was compared with the standard curve and 
the extract's flavonol amount was measured and 
expressed in mg/g dried extract. The amounts of 
phenolic, flavonolic, and flavonoid compounds were 
measured and expressed as mean ± standard deviation
(Rabiei et al., 2014). 
Laboratory animals
Adult male Balb/C mice weighing 25-30 g were kept at 
suitable (21 ± 2°C) temperature and 12/12 hours 
darkness: Light cycle with food and water freely 
available. 
Inducing physical dependence
On the first three days, 10 mg/kg body weight (BW) 
morphine solution per day was intraperitoneally 
injected. On the following three days, 20 mg/kg BW 
morphine solution per day was intraperitoneally 
injected and on the last three days, 40 mg/kg BW 
morphine solution per day was intraperitoneally 
injected (Kerachian et al., 2007).  
Group 1 (morphine-dependent group) (n=8) received 
intraperitoneally morphine for nine days and 1 mg/kg 
BW on the day 10, Group 2 (control group) (n=8) 
received  intraperitoneally 2 mL/kg BW normal saline, 
Group 3 (post-treatment group) (n=8) received intra-
peritoneally morphine for nine days and 100 mg B. 
officinalis extract one min after naloxone injection, 
Group 4 (co-treatment group) (n=8) received 
simultaneously morphine and 100 mg B. officinalis 
extract for nine days and 1 mg/kg BW naloxone on the 
day 10, Group 5 (extract group) (n=8) received B. 
officinalis extract for nine days and 1 mg/kg BW 
naloxone on the day 10. 
Inducing morphine withdrawal syndrome
On the day 10 after inducing physical dependence, 
naloxone (1 mg/kg BW) was injected intraperitoneally 
to induce the symptoms of morphine withdrawal 
syndrome (Kerachian  et al., 2007). 
Recording morphine withdrawal symptoms
After naloxone injection, the symptoms of morphine 
withdrawal, frequency of body stretching, jumping, 
paw trembling, blinking and ptosis were recorded for 
30 min (Kerachian et al., 2007). (Video Clip)
Statistical analysis
The data were analyzed by one-way ANOVA in SPSS 
16. Tukey's post-hoc test was used to investigate the 
significance of difference among the groups. p<0.05 was 
considered the level of significance and results were 
expressed in mean ± SEM.
Results 
The amounts of phenolic, flavonoid and flavonolid 
compounds of the B. officinalis extract are 44.9, 9.12 and 
4.24 mg/kg dried extract respectively.
Figure 1 illustrates the effect of B. officinalis extract, as co
-treatment and post-treatment, on the frequency of
naloxone-induced jumping in the morphine-dependent
mice. The frequency of jumping was significantly
higher in the morphine-dependent group than the
control group after naloxone injection (p<0.01). The
administration of 100 mg/kg hydroalcoholic B.
officinalis extract, as co-treatment and post-treatment,
caused a significant decrease in the frequency of
jumping (p<0.01). The frequency of jumping was
significantly different between the control group and
the group treated with B. officinalis extract alone
(p<0.01).
Figure 1 illustrates that the frequency of paw trembling 
was significantly higher in the morphine-dependent 
group than the control group after naloxone injection 
(p<0.01). Co-treatment and post-treatment with hydro-
alcoholic B. officinalis extract caused a significant 
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 decrease in the frequency of paw trembling compared 
to the morphine-dependent group (p<0.01). In addition, 
the frequency of paw trembling was not significantly 
different between the group treated with B. officinalis 
extract alone and the control group after naloxone 
injection (p<0.01).   
Figure 2 illustrates that the frequency of blinking was 
significantly higher in the morphine-dependent group 
than the control group after naloxone injection (p<0.05). 
The administration of 100 mg/kg hydroalcoholic B. 
officinalis extract on the day 10 before naloxane injection 
caused a significant decrease in the frequency of 
blinking compared to the morphine-dependent group 
(p<0.05). Simultaneous injection of B. officinalis extract 
and morphine for nine days caused a significant 
decrease in the frequency of blinking after naloxane 
injection compared to the morphine-dependent group 
(p<0.01). The frequency of blinking was significantly 
different between the control group and the group 
treated with B. officinalis extract alone (p<0.05). 
Figure 2 illustrates the effect of co-treatment and post-
treatment with B. officinalis extract on the frequency of 
ptosis in the morphine-dependent group. The 
frequency of ptosis was significantly higher in the 
morphine-dependent group than the control group 
after naloxone injection (p<0.01). Co-treatment and post
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Figure 2: The effect of Borago officinalis extract injection, as post-treatment and co-treatment, on the frequency of naloxone-induced 
blinking, rearing and ptosis in morphine-dependent mice; ap<0.05; bp=0.01-0.05; cp<0.01 
Figure 1: The effect of Borago officinalis extract injection, as post-treatment and co-treatment, on the frequency of naloxone-induced 
jumping and paw tremor in morphine-dependent mice; ap<0.01 
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 -treatment with B. officinalis extract caused a significant 
decrease in the frequency of ptosis compared to the 
morphine-dependent group (p<0.01). The frequency of 
ptosis was significantly different between the control 
group and the group treated with B. officinalis extract 
alone (p<0.01). 
Figure 2 illustrates the effect of 100 mg/kg B. officinalis, 
as treatment and post-treatment, on the frequency of 
two-legged standing in the mice with morphine 
withdrawal syndrome. The frequency of two-legged 
standing was significantly higher in the morphine-
dependent group than the control group (p<0.01). 
Hydroalcoholic B. officinalis extract, as treatment and 
post-treatment, caused a significant decrease in the 
frequency of two-legged standing compared to the 
morphine-dependent group (p<0.05). The frequency of 
two-legged standing was significantly different 
between the group treated with B. officinalis alone after 
naloxone injection and the morphine-dependent group 
(p<0.01).  
As Figure 3 illustrates, the amount of diarrhea was 
significantly higher in the morphine-dependent group 
than the control group after naloxone injection (p<0.01). 
Intraperitoneal administration of 100 mg/kg hydro-
alcoholic B. officinalis extract, as treatment and after 
treatment, caused a significant decrease in the diarrhea 
amount in the morphine-dependent group compared to 
the control group (p<0.01). Diarrhea amount was 
significantly lower in the group treated with the extract 
alone than the morphine-dependent group after nalo-
xone injection (p<0.05). 
Figure 4 illustrates the effect of co-treatment and post-
treatment with B. officinalis on the frequency of scrat-
ching in the mice with morphine withdrawal syn-
drome. The frequency of scratching was not signifi-
cantly different between the morphine-dependent 
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Figure 3: The effect of Borago officinalis extract injection, as post-treatment and co-treatment, on the amount of diarrhea after nalox-
one injection in morphine-dependent mice; ap=0.01-0.05; bp<0.05 
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Figure 4: The effect of Borago officinalis extract, as post-treatment and co-treatment, on the frequency of scratching in the morphine-
dependent mice after naloxone injection in morphine-dependent mice; ap<0.05; bp<0.01; ns: Not significant 
B. officinalis extract 
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 group and the control group after naloxone injection 
(p>0.05). Injecting hydroalcoholic B. officinalis extract  
on the day 10, 10 min before naloxone injection caused 
a significant decrease in the frequency of scratching 
compared to the morphine-dependent group (p<0.01). 
B. officinalis and morphine co-treatment caused no 
significant effect on the frequency of scratching after 
naloxone injection (p>0.05). The frequency of scratching 
was significantly different between the group adminis-
tered with the extract alone and the morphine-
dependent group after naloxone injection (p<0.05). 
 
Discussion 
Injecting naloxone caused increase in the frequency of 
jumping, blinking, ptosis, bowel movement, and paw 
trembling in the morphine-administered group com-
pared to the control group, but no significant effect was 
derived on scratching and abdominal twitching. Other 
studies reported that naloxone injection after morphine 
administration caused the symptoms of morphine 
withdrawal syndrome, including increased diarrhea, 
ptosis and snarling (Vafaei et al., 2011; Khajeh et al., 
2015) . 
Naloxone, as an opioid receptors antagonist, prevents 
opioid agonists from acting and prevents opioid 
receptors from accessing agonist molecules. This drug 
in administered intravenously and intensifies the 
symptoms of addiction withdrawal in opioid-depen-
dent people (Rafieian Kopaei et al., 1995) . 
In this study, co-treatment and post-treatment with B. 
officinalis extract caused a significant decrease in the 
frequency of morphine withdrawal syndrome, jumping, 
blinking, ptosis, bowel movement, scratching, and paw 
trembling. 
According to some studies on the symptoms of 
morphine withdrawal syndrome, diarrhea may occur 
because of morphine effect on cholinergic system
(Williams et al., 2001). Cholinergic, serotoninergic and 
gabaergic systems and possibly calcium ion are likely to 
involve in jumping, such that serotoninergic and 
cholinergic systems cause increase in jumping and 
GABAergic system cause decrease in jumping (Eriator 
1998). 
Flavonoid and phenolic compounds of the medicinal 
plants can inhibit cholinergic system function through 
inhibiting cholinesterase and therefore cause reduction 
in the symptoms of withdrawal syndrome (Baradaran 
et al., 2012). Given great amounts of flavonoid and 
phenolic compounds of B. officinalis flowers, the 
function could be attributed to the inhibitory effect on 
cholinergic system. However, further investigation is 
needed to examine this.  
Protein kinase inhibitors, calcium channel blockers and 
Rp-cAMPS, specific and strong inhibitor of protein 
kinase activation by cAMPS, can reduce the withdrawal 
symptoms in rats (Ouyang et al., 2012). Gilani et al. 
reported that B. officinalis extract exerted antispasmodic 
and bronchodilating effects through inhibiting calcium 
channels (Gilani et al., 2007). Therefore, inhibiting 
calcium channels may be considered a potential 
mechanism and investigated. 
Studies have indicated that baclofen, GABAB agonist, 
can reduce naloxone-induced withdrawal symptoms.  
In addition, certain drugs, such as benzodiazepine, can 
reduce naloxone-induced symptoms of morphine-
dependent rats (Maldonado et al., 1991). Given that the 
analgesic effect of B. officinalis has already been 
demonstrated (Shahraki et al., 2015), this plant is likely 
to reduce the symptoms of withdrawal syndrome 
through affecting gabaergic system. This deserves 
further investigation.  
In addition, opioid receptors are present in different 
sites, such as limbic system, spinal network pathways, 
intermediate nuclei, spinal gelatinous substance, spinal 
nucleus of trigeminal nerve, and the vagus nerve. These 
receptors are composed of various hairs, kappa, delta, 
epsilon, and sigma, any one of which has a distinct 
function (Maldonado et al., 1991) 
Any opioid receptors are likely to be activated during 
phythotherapy with B. officinalis. It is necessary to 
determine the role of opioid receptors in phythotherapy 
with B. officinalis using opioid receptor agonists and 
antagonists. Given that the therapeutic effects of 
hydroalcoholic B. officinalis extract on the symptoms of 
morphine withdrawal syndrome have been investi-
gated in this study for the first time, none of the com-
pounds of this extract can be considered responsible for 
reducing the symptoms of withdrawal syndrome. 
In this study, nine-day B. officinalis treatment followed 
by naloxone administration caused no significant 
change in the frequency of jumping, blinking, ptosis, 
bowel movements, and paw trembling compared to the 
control treatment. This confirms no induction of 
dependence on B. officinalis extract. 
Several studies have shown that B. officinalis contains 
secondary metabolites such as pyerolisidine alkaloids 
and should not be used in the long-term (Maldonado et 
al., 1991). In the present study, nine-day treatment 
followed by one post-treatment with B. officinalis extract 
caused a significant decrease in the symptoms of 
morphine withdrawal syndrome. Therefore, there is no 
need for the repeated use of this plant. 
 
Conclusion 
B. officinalis administration for nine days followed by 
naloxone administration caused no significant decrease 
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